Sublingual immunotherapy in daily medical practice: effectiveness of different treatment schedules – IPD meta-analysis

References

• Bousquet J, van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl 5):S147-334
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160
   PubMed Web of Science ®Google Scholar
• Bousquet J, Lockey R, Malling HJ, et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American Academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998;81:401-5
   PubMed Web of Science ®Google Scholar
• Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:4-12
   PubMed Web of Science ®Google Scholar
• Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97:141-8
   PubMed Web of Science ®Google Scholar
• Canonica GW, Bousquet J, Casale TB, et al. Sub-lingual immunotherapy. World Allergy Organization Position Paper 2009. Allergy 2009;64(Suppl 91):1-59
   Google Scholar
• Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007;120:1338-45
   PubMed Web of Science ®Google Scholar
• Ott H, Sieber J, Brehler R, et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009;64:1394-401
   PubMed Web of Science ®Google Scholar
• Frati F, Scurati S, Puccinelli P, et al. Development of an allergen extract for sublingual immunotherapy – evaluation of Staloral. Expert Opin Biol Ther 2009;9:1207-15
   PubMed Web of Science ®Google Scholar
• Gidaro GB, Marcucci F, Sensi L, et al. The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin Exp Allergy 2005;35:565-71
   PubMed Web of Science ®Google Scholar
• Feliziani V, Lattuada G, Parmiani S, et al. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol (Madr) 1995;23:224-30
   PubMedGoogle Scholar
• Vervloet D, Birnbaum J, Laurent P, et al. Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis. A double-blind, placebo-controlled study. Int Arch Allergy Immunol 2007;142:239-46
   PubMed Web of Science ®Google Scholar
• Gammeri E, Arena A, D’Anneo R, et al. Safety and tolerability of ultra-rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma. Allergol Immunopathol (Madr) 2005;33:142-4
   PubMedGoogle Scholar
• Tripodi S, Di Rienzo Businco A, Benincori N, et al. Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children. Int Arch Allergy Immunol 2006;139:149-52
   PubMed Web of Science ®Google Scholar
• Seidenberg J, Pajno GB, Bauer CP, et al. Safety and tolerability of seasonal ultra-rush high-dose sublingual-swallow immunotherapy in allergic rhinitis to grass and tree pollens: an observational study in 193 children and adolescents. J Investig Allergol Clin Immunol 2009;19:125-31
   PubMed Web of Science ®Google Scholar
• Ariano R, Incorvaia C, La Grutta S, et al. Safety of sublingual immunotherapy started during the pollen season. Curr Med Res Opin 2009;25:103-7
   PubMed Web of Science ®Google Scholar
• de Groot H, Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy 2009;64:963-4
   PubMed Web of Science ®Google Scholar
• Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998;53:493-8
   PubMed Web of Science ®Google Scholar
• Wahn U, Tabar A, Kuna P, et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009;123:160-6 e3
   PubMed Web of Science ®Google Scholar
• Golden DB, Valentine MD, Kagey-Sobotka A, et al. Regimens of Hymenoptera venom immunotherapy. Ann Intern Med 1980;92:620-4
   PubMed Web of Science ®Google Scholar
• Vent J, Lehmacher W. The problem of placebo-controlled trials allowing rescue medication: how to assess efficacy in rhinosinusitis and allergic rhinoconjunctivitis when both groups receive active rescue treatment. Curr Opin Allergy Clin Immunol 2009;9:222-7
   PubMed Web of Science ®Google Scholar
• Khinchi MS, Poulsen LK, Carat F, et al. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004;59:45-53
   PubMed Web of Science ®Google Scholar
• Di Rienzo V, Pagani A, Parmiani S, et al. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999;54:1110-13
   PubMed Web of Science ®Google Scholar
• Di Rienzo V, Minelli M, Musarra A, et al. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy 2005;35:560-4
   PubMed Web of Science ®Google Scholar
• Drachenberg KJ, Urban E, Proll S, et al. Sublingual specific immunotherapy for adults and children: a post-marketing surveillance study. Allergol Immunopathol (Madr) 2004;32:76-81
   PubMedGoogle Scholar
• Fiocchi A, Pajno G, La Grutta S, et al. Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. Ann Allergy Asthma Immunol 2005;95:254-8
   PubMed Web of Science ®Google Scholar
• Rolinck-Werninghaus C, Wolf H, Liebke C, et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004;59:1285-93
   PubMed Web of Science ®Google Scholar
• Bodtger U, Poulsen LK, Malling HJ. Retrospective assessment of seasonal allergic symptoms: over-rating but useful. Clin Exp Allergy 2003;33:496-500
   PubMed Web of Science ®Google Scholar
• Flay BR. Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs. Prev Med 1986;15:451-74
   PubMed Web of Science ®Google Scholar
• Revicki DA, Frank L. Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies. Pharmacoeconomics 1999;15:423-34
   PubMed Web of Science ®Google Scholar
• Sutton A, Abrams K, Jones D, et al. Methods for meta-analysis in medical research. Chichester: Wiley & Sons, 2000
   Google Scholar
• Friedenreich CM. Methods for pooled analyses of epidemiologic studies. Epidemiology 1993;4:295-302
   PubMed Web of Science ®Google Scholar